Pfizer’s COVID Vaccine Gets Full Approval From The FDA

Enlarge this image


A nurse is handed a dose of the Pfizer Covid-19 vaccine before administering it to a college student during a mobile vaccination clinic at the California State University, Long Beach, on Aug. 11.





Patrick T. Fallon/AFP via Getty Images



hide caption



toggle caption


Patrick T. Fallon/AFP via Getty Images



Shots — Health News
New Evidence Points To Antibodies As A Reliable Indicator Of Vaccine Protection

A June poll from the Kaiser Family Foundation found that 31% of unvaccinated people said they would be more likely to get a COVID-19 vaccine once one receives full approval from the FDA.

«While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated, acting FDA Commissioner Janet Woodcock said in a statement. «Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.

The FDA acted Monday without convening a customary public meeting of expert advisers to vet information about the vaccine and make recommendations to the regulator.

As of Sunday, 73% of adults have had at least one dose of the Pfizer, Moderna or Johnson & Johnson vaccine. Pfizer’s vaccine is most commonly administered, accounting for about 56% of the doses administered overall, according to data from the Centers for Disease Control and Prevention.

Moderna’s COVID-19 vaccine remains under FDA’s review, but its approval is expected to follow in the near future.